http://www.abc.net.au/news/rural/2014-08-15/dist-sandalwood-sale/5673180
to quote:
"Tropical Forestry Services (TFS) announced in March it had signed a deal expected to be worth half a billion dollars with a pharmaceutical company."
"The company's head of global products Mario Di Lallo says Galderma will use the oil in various products."
"Mr Di Lallo won't confirm how much oil is expected to be produced, but says TFS is expecting Galderma to buy majority of it."
also from the west australian article
"Perth-based TFS is the world's only supplier of pharmaceutical- grade sandalwood oil. Mr Wilson believes Galderma has the potential to take a big proportion of the oil produced from trees on 9000ha of plantations it manages in northern Australia."
This was all on top of the fact that UBS published a note saying that they believed the santalis division could be spun off into its own listed company.
i find your statements and the statements given to the media at the time of the contract being signed to be highly contradictory. i would invite other users to read the stories and quotes from management at the time of the galderma contract versus now and make their own conclusions.
- Forums
- ASX - By Stock
- QIN
- Latest News / Resolution at AGM
Latest News / Resolution at AGM, page-69
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online